UNBSF (Uni-Bio Science Group) Notes Receivable: $0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UNBSF Uni-Bio Science Group Ltd UNBSF
58 GF Score
Price $0.00
GF Value $0.01
! 3 Warning Signs
View Full Analysis

What is Uni-Bio Science Group Notes Receivable?

Uni-Bio Science Group UNBSF 58 Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates UNBSF with a GF Score™ of 58/100 and a GF Value™ of $0.01. The stock has 3 warning signs investors should review.

Uni-Bio Science Group's Notes Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.

Uni-Bio Science Group Notes Receivable Related Terms

Uni-Bio Science Group Notes Receivable Historical Data

* Premium members only.

The historical data trend for Uni-Bio Science Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uni-Bio Science Group Notes Receivable Chart

Uni-Bio Science Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Uni-Bio Science Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
UNBSF
58GF Score
Uni-Bio Science Group Ltd UNBSF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uni-Bio Science Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Uni-Bio Science Group (UNBSF) has a Notes Receivable of $0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Uni-Bio Science Group and its competitors.
Is Uni-Bio Science Group's Notes Receivable too high?
Uni-Bio Science Group's current Notes Receivable is $0.00 Mil. Overall, Uni-Bio Science Group has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Uni-Bio Science Group's Notes Receivable compare to VRTX and REGN?
Uni-Bio Science Group's Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Uni-Bio Science Group and its competitors. Uni-Bio Science Group's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uni-Bio Science Group stock overvalued right now?
Uni-Bio Science Group (UNBSF) has a current Notes Receivable of $0.00 Mil. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 60% below its estimated fair value. The current Notes Receivable is $0.00 Mil. Uni-Bio Science Group's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Uni-Bio Science Group (UNBSF), the current Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uni-Bio Science Group (UNBSF) Overvalued in 2026?

Based on GuruFocus' analysis, Uni-Bio Science Group stock appears to be undervalued. The current stock price of $0.00 is trading 60% below its estimated GF Value™ of $0.01.

Key valuation signals for UNBSF:

  • Notes Receivable: $0.00 Mil
  • GF Value™: $0.01 vs. price of $0.00 (60% below fair value)
  • GF Score™: 58/100 with 3 warning signs

No single metric tells the full story. See the UNBSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Uni-Bio Science Group Business Description

Other Exchanges 00690:Hong Kong
Address No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG
Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.
58GF Score

Get the complete analysis for UNBSF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price
$0.01
GF Value